By 2025, the sector could explode to a value of $727.1 billion at a CAGR of 7.4%, according to Grand View Research thanks to sizable near-term catalysts. This sector could be one of the safest, most recession-proof investments around, because we can’t stop folks from aging, and needing treatments for a large range of medical … Continue reading “The Top Biotech Penny Stocks for 2020”